Lifecore segment revenues increased 27.9% in fiscal third quarter, as compared to prior year period Reiterates fiscal 2022 full year guidance SANTA MARIA, Calif. , April 05, 2022 (GLOBE NEWSWIRE) -- Landec Corporation (Nasdaq: LNDC) (“Landec” or the “Company”), a diversified health and wellness
SANTA MARIA, Calif. , March 22, 2022 (GLOBE NEWSWIRE) -- Landec Corporation (Nasdaq: LNDC) (“Landec” or the “Company”), a diversified health and wellness company focused on its growing Lifecore Biomedical (“Lifecore”) business – a fully integrated contract development and manufacturing organization
SANTA MARIA, Calif. , Jan. 07, 2022 (GLOBE NEWSWIRE) -- Landec Corporation (Nasdaq: LNDC) (“Landec” or the “Company”), a diversified health and wellness company focused on its growing Lifecore Biomedical (“Lifecore”) business – a fully integrated contract development and manufacturing organization
Reiterates Fiscal 2022 Guidance for Lifecore Provides Pro Forma Curation Foods Segment Results and Updates Guidance for Continuing Segment Operations SANTA MARIA, Calif. , Jan. 05, 2022 (GLOBE NEWSWIRE) -- Landec Corporation (Nasdaq: LNDC) (“Landec” or the “Company”), a diversified health and
Strategic sale results in a CDMO-focused company aligned with attractive growth categories and end markets Net proceeds from the sale will be allocated towards debt pay down, resulting in significant deleveraging Announces fiscal second quarter earnings call on January 5, 2022 SANTA MARIA, Calif.
Quarterly net loss of $9.5 million , EBITDA of $1.1 million , and Adjusted EBITDA of $4.4 million Reiterates Fiscal Year 2022 Guidance SANTA MARIA, Calif. , Sept. 29, 2021 (GLOBE NEWSWIRE) -- Landec Corporation (Nasdaq: LNDC), a diversified health and wellness company with two operating businesses,
SANTA MARIA, Calif. , Sept. 15, 2021 (GLOBE NEWSWIRE) -- Landec Corporation (Nasdaq: LNDC), a diversified health and wellness company with two operating businesses, Lifecore Biomedical, Inc. and Curation Foods, Inc. , will hold a conference call on Wednesday, September 29, 2021 at 2 p.m.
Lifecore Biomedical Generates Full Year Revenue Growth of 14.3%, Net Income Growth of 23.1%, and Adjusted EBITDA Growth of 22.0% Curation Foods Achieves Fiscal Fourth Quarter Gross Margin of 11.9% on Revenue of $114.0 Million Landec Consolidated Full Year Revenues of $544.2 Million , Net Loss of
SANTA MARIA, Calif. , July 14, 2021 (GLOBE NEWSWIRE) -- Landec Corporation (Nasdaq: LNDC), a diversified health and wellness company with two operating businesses, Lifecore Biomedical, Inc. and Curation Foods, Inc. , will hold a conference call on Wednesday, July 28, 2021 at 2 p.m.
Early sale to affiliates of founding and controlling investors for $45.1 million Net proceeds to be used to repay a portion of outstanding term debt and de-lever balance sheet SANTA MARIA, Calif. , June 01, 2021 (GLOBE NEWSWIRE) -- Landec Corporation (Nasdaq: LNDC), a diversified health and